BI-RADS Breast Density Assessment
Standardized breast density classification for mammography reporting. Guide supplemental screening decisions.
BI-RADS breast density categorises the relative amount of fibroglandular tissue versus fat on mammography, standardising reporting under the ACR Breast Imaging Reporting and Data System. Density affects mammographic sensitivity because dense tissue can mask cancers, and it is an independent risk factor for breast cancer. The assessment guides communication with patients and decisions about supplemental screening.
🧮 Interactive Calculator
📐 Formula
A: Almost entirely fatty. B: Scattered fibroglandular. C: Heterogeneously dense (may obscure masses). D: Extremely dense (lowers sensitivity)
Reference: ACR BI-RADS 5th Edition
When to Use
- Every screening and diagnostic mammogram report, as a required BI-RADS element
- Counselling patients on masking risk and personal breast cancer risk
- Deciding whether to offer supplemental screening (ultrasound, MRI) in dense breasts
- Complying with breast density notification legislation where applicable
- Longitudinal comparison of density across serial mammograms
How It Works
- The radiologist assigns one of four qualitative categories (A-D) based on the overall proportion and distribution of fibroglandular tissue, emphasising the potential to obscure a mass rather than a strict percentage.
- Category A: the breasts are almost entirely fatty.
- Category B: scattered areas of fibroglandular density.
- Category C: heterogeneously dense, which may obscure small masses.
- Category D: extremely dense, which lowers the sensitivity of mammography.
- Since BI-RADS 5th edition, assignment is based on masking potential and the densest region, not simply the overall percentage; automated volumetric software can assist but the final category is a visual judgement.
- Categories C and D are collectively termed 'dense breasts'.
Interpreting the Result
- Categories A and B (non-dense): mammographic sensitivity is generally high and supplemental screening is not routinely indicated on density grounds alone.
- Categories C and D (dense): reduced mammographic sensitivity from masking, plus an increased relative risk of breast cancer.
- Category D confers the greatest masking effect and, alongside C, prompts consideration of supplemental ultrasound or MRI depending on overall risk.
- Density is one input into overall risk assessment; combine with family history, prior biopsy, and risk models when advising supplemental screening.
- A change to a denser category can occur with hormone therapy; a change to less dense with age or antioestrogen therapy.
- The category informs communication (density notification) even when the mammogram is otherwise normal (BI-RADS 1 or 2).
Limitations & Pitfalls
- Assignment is subjective with significant inter- and intra-observer variability, especially between categories B and C.
- It is a qualitative masking judgement, not a precise percentage of fibroglandular tissue.
- Density alone does not determine management; it must be integrated with a formal risk assessment.
- Automated volumetric tools may disagree with visual assessment and are not universally standardised.
- Density can change over time with age, hormonal status, and weight, so single-timepoint categorisation may be transient.
- The category conveys masking and risk but does not itself diagnose or exclude malignancy.
References
- American College of Radiology. ACR BI-RADS Atlas, 5th edition. 2013.
- Boyd NF et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007.
- Sickles EA et al. ACR BI-RADS Mammography (Atlas chapter). 2013.
- Melnikow J et al. Supplemental screening for breast cancer in women with dense breasts: USPSTF systematic review. Ann Intern Med. 2016.
⚕️ For clinical decision support only. Always verify calculations and apply clinical judgment.